-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FqF4G32m28hozPF7nZC6xowkDlT6k3j5FxV1HBQl9TlhddDEdc/rdxcecQ230TXk y4GapFHaLVw4uFzQaCJflw== 0001144204-10-000159.txt : 20100104 0001144204-10-000159.hdr.sgml : 20100101 20100104163541 ACCESSION NUMBER: 0001144204-10-000159 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100104 FILED AS OF DATE: 20100104 DATE AS OF CHANGE: 20100104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kogan Yakov CENTRAL INDEX KEY: 0001370084 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32954 FILM NUMBER: 10502745 MAIL ADDRESS: STREET 1: 11000 CEDAR AVE. STREET 2: SUITE 280 CITY: CLEVELAND STATE: OH ZIP: 44106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CLEVELAND BIOLABS INC CENTRAL INDEX KEY: 0001318641 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 200077155 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 73 HIGH STREET CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: (716) 849-6810 MAIL ADDRESS: STREET 1: 73 HIGH STREET CITY: BUFFALO STATE: NY ZIP: 14203 4 1 v170407_ex.xml X0303 4 2010-01-04 0 0001318641 CLEVELAND BIOLABS INC CBLI 0001370084 Kogan Yakov 73 HIGH STREET BUFFALO NY 14203 1 1 0 0 COO, Secretary Common Stock 2010-01-04 4 S 0 5800 3.50 D 685400 D Common Stock 2010-01-04 4 S 0 200 3.51 D 685200 D Employee Stock Options (Right to Buy) 8.36 2007-04-06 2017-04-05 Common Stock 37500 37500 D Employee Stock Options (Right to Buy) 4.00 2008-02-04 2018-02-03 Common Stock 137250 174750 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and represent approximately 0.8% of the reporting person's 715,200 shares held prior to adoption of the plan. The maximum sales subject to the plan in its entirety represent approximately 10.1% of the reporting person's shares held prior to adoption of the plan. /s/ Yakov Kogan 2010-01-04 -----END PRIVACY-ENHANCED MESSAGE-----